As the obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a ...

The trial is funded in part by a $30m grant from the US Biomedical Advanced Research and Development Authority (BARDA).

Pfizer has announced data from the Phase III trial of TALZENNA plus XTANDI in patients with metastatic castration-resistant ...

Clario and PathAI partnered to offer an integrated solution for enhancing efficiency of gastrointestinal (GI) clinical trials ...

The trial will assess Radspherin for the treatment of peritoneal carcinomatosis originating from ovarian cancer. Credit: ...